Axsome Therapeutics (AXSM) EPS (Basic) Growth (3y) (2018 - 2026)
Axsome Therapeutics (AXSM) EPS (Basic) Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 53.55% |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.57 Bn | 466.77 Bn | 1.35 Bn | 37.73% |
| 5 | Vertex Pharmaceuticals | 122.01 Bn | 114.76 Bn | 2.59 Bn | 14.29% |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | -2.89% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | 86.43% |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn | 45.89% |
| 10 | Axsome Therapeutics | 12.26 Bn | 11.95 Bn | 176.48 Mn | -69.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.64% |
| Dec 31, 2025 | 27.44% |
| Sep 30, 2025 | 4.23% |
| Jun 30, 2025 | 2.91% |
| Mar 31, 2025 | -5.54% |
| Dec 31, 2024 | -18.75% |
| Sep 30, 2024 | 38.70% |
| Jun 30, 2024 | 34.05% |
| Mar 31, 2024 | -21.09% |
| Dec 31, 2023 | -38.92% |
| Sep 30, 2023 | 40.64% |
| Jun 30, 2023 | 41.02% |
| Mar 31, 2023 | 33.72% |
| Dec 31, 2022 | -26.71% |
| Sep 30, 2022 | 12.99% |
| Jun 30, 2022 | 20.05% |
| Mar 31, 2022 | -46.56% |
| Dec 31, 2021 | -68.50% |
| Sep 30, 2021 | -153.39% |
| Jun 30, 2021 | -153.53% |